Insider Transactions last 24 months for Aprea Therapeutics, Inc.  -  NSDQ: APRE

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Bizzari Jean-PierreDirector06/05/2025AADirectCOM1,045$0.00$0.001,045
Duey MarcDirector06/05/2025AADirectCOM1,045$0.00$0.00234,696
Grissinger MichaelDirector06/05/2025AADirectCOM1,045$0.00$0.002,889
Gruia GabrielaDirector06/05/2025AADirectCOM1,045$0.00$0.001,045
Henneman John B IiiDirector06/05/2025AADirectCOM1,045$0.00$0.0010,229
Pamukcu RifatDirector06/05/2025AADirectCOM1,045$0.00$0.005,446
Peters RichardDirector06/05/2025AADirectCOM1,045$0.00$0.003,119
Seizinger Bernd R.Director06/05/2025AADirectCOM1,045$0.00$0.0045,775
Gilad OrenPresident/CEO04/03/2025APDirectCOM2,497$1.80$4,494.60345,620
Gilad OrenPresident/CEO04/03/2025APDirectCOM3,003$1.87$5,615.61343,123
Gilad OrenPresident/CEO03/27/2025AADirectCOM6,725$0.00$0.00340,120
Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr03/27/2025AADirectCOM3,365$0.00$0.0022,733
Gilad OrenPresident/CEO10/23/2024APDirectCOM500$3.92$1,957.50333,395
Duey MarcDirector10/18/2024DSDirectCOM6,462$4.58$29,583.04233,651
Duey MarcDirector10/16/2024APDirectCOM30,000$4.39$131,700.00240,113
Gilad OrenPresident/CEO10/15/2024APDirectCOM250$2.90$725.00332,895
Gilad OrenPresident/CEO10/14/2024APDirectCOM1,000$2.59$2,590.00332,645
Duey MarcDirector10/14/2024APDirectCOM190$2.58$490.20210,113
Seizinger Bernd R.Director10/11/2024APDirectCOM10,000$2.68$26,800.0044,730
Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr10/11/2024APDirectCOM50$2.46$123.1919,368
Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr10/10/2024APDirectCOM450$2.61$1,174.5019,318
Gilad OrenPresident/CEO10/10/2024APDirectCOM150$2.54$381.00331,645
Duey MarcDirector06/20/2024AADirectCOM1,045$0.00$0.00209,923
Grissinger MichaelDirector06/20/2024AADirectCOM1,045$0.00$0.001,844
Henneman John B IiiDirector06/20/2024AADirectCOM1,045$0.00$0.009,184
1   2  Next Last  You are at page 1 of 2 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel